Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -92.94% is 53% above its 5-year average of -199.33%, near the high end of its 5-year range (-5485.45%–-89.99%).
As of the fiscal period ended Tuesday, June 30, 2026. 92.45% above its 12-month average of -1231.66%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -92.94%.
RETURN ON INVESTED CAPITAL (ROIC)
-92.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-1231.66%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-855.77%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-199.33%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+92.45%
CURRENT VS 3Y AVG
+89.14%
CURRENT VS 5Y AVG
+53.37%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-160.73%
vs the sector median at left
CNS Pharmaceuticals, Inc.
Market Cap
$7.75M
Return on Invested Capital (ROIC)
-92.94%
TTM Avg
-1231.66%
3Y Avg
-855.77%
5Y Avg
-199.33%
Market Cap
$7.67M
Return on Invested Capital (ROIC)
-92.93%
TTM Avg
-227.52%
3Y Avg
-201.78%
5Y Avg
-175.64%
Market Cap
$7.64M
Return on Invested Capital (ROIC)
-102.91%
TTM Avg
-91.30%
3Y Avg
-374.81%
5Y Avg
-315.39%
Market Cap
$7.87M
Return on Invested Capital (ROIC)
-33.73%
TTM Avg
-84.97%
3Y Avg
-168.83%
5Y Avg
-136.52%
Market Cap
$7.92M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-259.12%
3Y Avg
-153.58%
5Y Avg
-167.70%
Market Cap
$7.46M
Return on Invested Capital (ROIC)
-107.08%
TTM Avg
-63.63%
3Y Avg
-49.78%
5Y Avg
-53.46%
Market Cap
$8.04M
Return on Invested Capital (ROIC)
-457.75%
TTM Avg
-214.65%
3Y Avg
-192.14%
5Y Avg
-209.63%
Market Cap
$8.05M
Return on Invested Capital (ROIC)
-439.90%
TTM Avg
-355.30%
3Y Avg
-355.30%
5Y Avg
-355.30%
Market Cap
$8.14M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-174.21%
3Y Avg
-638.36%
5Y Avg
-516.05%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CNS Pharmaceuticals, Inc. (CNSP) | $7.75M | -92.94% | -1231.66% | -855.77% | -199.33% |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.67M | -92.93% | -227.52% | -201.78% | -175.64% |
| Mangoceuticals, Inc. (MGRX)vs › | $7.64M | -102.91% | -91.30% | -374.81% | -315.39% |
| Aprea Therapeutics, Inc. (APRE)vs › | $7.87M | -33.73% | -84.97% | -168.83% | -136.52% |
| Traws Pharma, Inc. (TRAW)vs › | $7.92M | N/A | -259.12% | -153.58% | -167.70% |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.46M | -107.08% | -63.63% | -49.78% | -53.46% |
| GT Biopharma, Inc. (GTBP)vs › | $8.04M | -457.75% | -214.65% | -192.14% | -209.63% |
| DataMEDS AI, Inc. (MEDS)vs › | $8.05M | -439.90% | -355.30% | -355.30% | -355.30% |
| HeartSciences Inc. (HSCS)vs › | $8.14M | N/A | -174.21% | -638.36% | -516.05% |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | -995.44% | -481.38% | -268.85% | -219.77% |
ROIC
-92.9%
ROE
-91.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -92.94% |
| 2026-03-31 | -5485.45% |
| 2025-12-31 | -329.54% |
| 2025-09-30 | -132.79% |
| 2025-06-30 | -117.58% |
| 2025-03-31 | -140.37% |
| 2024-12-31 | -229.17% |
| 2024-09-30 | -504.84% |
| 2023-06-30 | -669.21% |
| 2023-03-31 | -451.68% |
| 2022-12-31 | -179.10% |
| 2022-09-30 | -153.27% |
| 2022-06-30 | -114.04% |
| 2022-03-31 | -89.99% |
| 2021-12-31 | -200.12% |
| 2021-09-30 | -155.68% |
| 2021-06-30 | -98.79% |
| 2021-03-31 | -96.05% |
| 2020-12-31 | -65.72% |
| 2020-09-30 | -362.77% |
| 2020-06-30 | -205.79% |
| 2020-03-31 | -95.42% |
| 2019-12-31 | -50.43% |
| 2019-09-30 | -505.58% |
| 2019-06-30 | -145.88% |
